Baikowski SASU
Baikowski SA, together with its subsidiaries, produces and sells specialty chemicals in France, rest of Europe, the Americas, Asia, and internationally. The company offers ultra-pure alumina powders and formulations, spinel, ZTA/ATZ, YAG, mullite, polishing solutions, nanodispersions, and ready-to-use solutions for technical ceramics, precision polishing, crystals, additives, and coatings applica… Read more
Baikowski SASU (ALBKK) - Total Liabilities
Latest total liabilities as of June 2025: €25.80 Million EUR
Based on the latest financial reports, Baikowski SASU (ALBKK) has total liabilities worth €25.80 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Baikowski SASU - Total Liabilities Trend (2016–2024)
This chart illustrates how Baikowski SASU's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Baikowski SASU Competitors by Total Liabilities
The table below lists competitors of Baikowski SASU ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Pharmx Technologies Ltd
AU:PHX
|
Australia | AU$2.90 Million |
|
FORCS Co.Ltd
KQ:189690
|
Korea | ₩5.51 Billion |
|
Wintergreen Acquisition Corp. Ordinary Shares
NASDAQ:WTG
|
USA | $66.27K |
|
WVS Financial Corp
OTCQX:WVFC
|
USA | $316.87 Million |
|
Immunovia AB (publ)
PINK:IMMVF
|
USA | $23.42 Million |
|
Autech Corporation
KQ:067170
|
Korea | ₩482.93 Billion |
|
Airsculpt Technologies Inc
NASDAQ:AIRS
|
USA | $103.81 Million |
|
CItech Co Ltd
KO:004920
|
Korea | ₩38.91 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Baikowski SASU's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.54 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Baikowski SASU's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Baikowski SASU (2016–2024)
The table below shows the annual total liabilities of Baikowski SASU from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €23.54 Million | +0.44% |
| 2023-12-31 | €23.43 Million | -2.09% |
| 2022-12-31 | €23.93 Million | -0.99% |
| 2021-12-31 | €24.18 Million | -24.03% |
| 2020-12-31 | €31.82 Million | -7.90% |
| 2019-12-31 | €34.55 Million | +26.92% |
| 2018-12-31 | €27.23 Million | +17.12% |
| 2017-12-31 | €23.25 Million | -0.83% |
| 2016-12-31 | €23.44 Million | -- |